Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience
about
Controversies in the management of primary sclerosing cholangitisBrazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverEndoscopic management of benign biliary stricturesRisk stratification in autoimmune cholestatic liver diseases: Opportunities for clinicians and trialistsCurrent diagnostic and management options in perihilar cholangiocarcinomaCholangiocarcinomaAngiopoietin-2 and biliary diseases: elevated serum, but not bile levels are associated with cholangiocarcinoma.Treatment of autoimmune liver disease: current and future therapeutic options.Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitisPrognostic value of neutrophil distribution in cholangiocarcinoma.The Prognostic Role of SOCS3 and A20 in Human CholangiocarcinomaIncidence of subsequent cholangiocarcinomas after another malignancy: trends in a population-based study.Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches.Genetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing CholangitisEvaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing CholangitisPatients with primary sclerosing cholangitis require more sedation during endoscopic retrograde cholangiographyMRI of cholangiocarcinoma.Endoscopic management of benign biliary strictures.Screening for malignancy in primary sclerosing cholangitis (PSC).Diagnosis and management of primary sclerosing cholangitis-perspectives from a therapeutic endoscopist.New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis.Are Dominant Strictures in Primary Sclerosing Cholangitis a Risk Factor for Cholangiocarcinoma?Recommendations on the use of MRI in PSC-A position statement from the International PSC study group.The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.The evolution of natural history of primary sclerosing cholangitis.What is the current role of endoscopy in primary sclerosing cholangitis?Fut2 genotype is a risk factor for dominant stenosis and biliary candida infections in primary sclerosing cholangitis.Cholangiocarcinoma and its mimickers in primary sclerosing cholangitis.New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.Epidemiology and surgical management of intrahepatic cholangiocarcinoma
P2860
Q26765804-7ACA18F6-C96A-43DB-8A3E-46D53F2346BAQ26766699-62ED125D-E82F-4ADE-A700-9EA73EA9D600Q26795782-885AFB17-616F-4287-8522-0D3A8355962BQ26796355-571317BC-B1D0-4D56-8C31-AFFCB5EC82D8Q26822808-A43198D6-9AD5-411E-8341-0EEC37AB1BFEQ27001694-2048A93D-8793-41A5-9500-769B497624FCQ33605089-C10ECBEA-7958-4BBD-93DD-F2F2C23239D5Q34342199-FB0608AC-9DEE-442C-B421-21070156EE49Q35146460-6F67EF29-0C67-4FD4-8AE5-BF52EC6CFC3CQ35534078-BE53FB46-203A-4D9A-B484-FB98074E3B36Q35814659-89A0C160-D97D-452D-B2AB-8058A41B0381Q36009443-5412A5FB-C49D-475A-9BF4-7E64283F49B9Q36325130-5B7E061D-0AF1-4801-8D85-0AA7D9F375ACQ36805289-C6B37903-3E24-4561-A6BA-4E24127FFBA9Q37206473-21406CA6-9059-4D04-8595-E0D0C1E76A4FQ37740241-79CEE143-3C32-49F4-A46B-8C3C34DB9009Q38275161-0A993332-19B2-4EED-8C1F-1C3DF2621F49Q38329038-D618C154-A27F-47BF-98CF-81C101907D21Q38383074-02301A2D-5DA2-4E1F-B854-96826FB01601Q38443665-7474E06F-040E-466F-A141-5E9E95DF6B25Q38645109-877FF71B-C050-4A76-811D-91E9E4721A87Q38657903-0D95D95F-4904-40E8-8DFE-B6D975542237Q38677506-95C96C46-B83E-4D84-9896-BBB6DB1C9B73Q38846826-B6B650D6-411E-49A2-AEE0-6A289340BFB8Q39058954-D322DE31-9905-4247-ABA7-C8BA0C37E454Q42428693-FAD9E5EC-665E-4A19-AD6C-9A16F4423F5DQ45375843-20273E88-CA4A-4582-B906-1EA187834082Q48283681-5354FC45-B6A9-4325-836C-F16E09DEA5A8Q50050635-06A39A25-0C6E-4702-9484-59A1753A3FAAQ52972733-C8238514-84F6-40FF-981E-53F4BE07108FQ57139999-8E76D75E-0403-48AD-B488-4B20175F856A
P2860
Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Cholangiocarcinoma and dominan ...... -year single-centre experience
@ast
Cholangiocarcinoma and dominan ...... -year single-centre experience
@en
type
label
Cholangiocarcinoma and dominan ...... -year single-centre experience
@ast
Cholangiocarcinoma and dominan ...... -year single-centre experience
@en
prefLabel
Cholangiocarcinoma and dominan ...... -year single-centre experience
@ast
Cholangiocarcinoma and dominan ...... -year single-centre experience
@en
P2093
P2860
P1476
Cholangiocarcinoma and dominan ...... -year single-centre experience
@en
P2093
Gavin J Johnson
George J M Webster
Johannes Wittmann
Michael H Chapman
Selina Bannoo
P2860
P304
P356
10.1097/MEG.0B013E3283554BBF
P577
2012-09-01T00:00:00Z